This guest lecture will provide an overview of Canada’s reimbursement landscape for drugs and medical devices, outlining the key pathways, processes, and stakeholders involved. Participants will gain insights into the intersection of regulatory affairs, health economics, and market access, and learn practical strategies to navigate this complex environment. The session will also highlight emerging trends and best practices shaping reimbursement success in the Canadian life sciences sector.
